Observational Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Apr 21, 2019; 25(15): 1890-1898
Published online Apr 21, 2019. doi: 10.3748/wjg.v25.i15.1890
Figure 4
Figure 4 Expression of serum exosomal microRNA-224 in hepatocellular carcinoma patients. A: Relative expression of serum exosomal microRNA-224 (miR-224) in hepatocellular carcinoma (HCC) and normal controls. B and C: Relative expression of serum exosomal miR-224 in HCC patients based on tumor size and tumor stage. D: The receiver operating characteristic curve of miR-224 for diagnosing HCC. cP < 0.001. NC: Normal controls; HCC: Hepatocellular carcinoma; ROC: Receiver operating characteristic; AUC: Area under the curve; CI: Confidence interval; miR-224: MicroRNA-224.